Boundless Bio Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Zach Hornby
Chief executive officer
US$2.4m
Total compensation
| CEO salary percentage | 20.9% |
| CEO tenure | 5yrs |
| CEO ownership | 1.2% |
| Management average tenure | 2.3yrs |
| Board average tenure | 2.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$53m |
| Dec 31 2023 | US$2m | US$495k | -US$49m |
| Sep 30 2023 | n/a | n/a | -US$49m |
| Jun 30 2023 | n/a | n/a | -US$49m |
| Mar 31 2023 | n/a | n/a | -US$47m |
| Dec 31 2022 | US$693k | US$476k | -US$46m |
Compensation vs Market: Zach's total compensation ($USD2.37M) is above average for companies of similar size in the US market ($USD1.58M).
Compensation vs Earnings: Zach's compensation has increased whilst the company is unprofitable.
CEO
Zach Hornby (44 yo)
5yrs
Tenure
US$2,372,863
Compensation
Mr. Zachary Hornby, also known as Zach, serves as Director at Radionetics Oncology, Inc. since October 2021. He serves as Director at Novome Biotechnologies, Inc. since May 2021. He is also a member of the...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Independent Chairman | 5.4yrs | US$61.17k | 0.46% $ 1.2m | |
| CEO, President & Director | 5yrs | US$2.37m | 1.15% $ 2.9m | |
| Chief Scientific Officer | 4.5yrs | US$903.51k | 0.12% $ 290.0k | |
| Chief Medical Officer | 2.3yrs | US$996.66k | 0% $ 0 | |
| Chief Financial Officer | less than a year | no data | no data | |
| Chief Legal Officer & Corporate Secretary | 2.8yrs | no data | no data | |
| Chief Business Officer | 2.8yrs | no data | no data | |
| Senior Vice President of Drug Discovery | 2.3yrs | no data | no data | |
| Senior Vice President of Talent & Culture | 2.3yrs | no data | no data | |
| Senior Vice President of Discovery & Translational Development | 1.1yrs | no data | no data | |
| Senior Vice President of Precision Medicine | less than a year | no data | no data | |
| Senior VP of Finance & Controller | 2.9yrs | no data | no data |
2.3yrs
Average Tenure
50yo
Average Age
Experienced Management: BOLD's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Independent Chairman | 5.4yrs | US$61.17k | 0.46% $ 1.2m | |
| CEO, President & Director | 5yrs | US$2.37m | 1.15% $ 2.9m | |
| Member of Clinical Advisory Board | less than a year | no data | no data | |
| Independent Director | 4.9yrs | no data | no data | |
| Scientific & Clinical Advisor | no data | US$92.28k | no data | |
| Independent Director | 2.3yrs | US$66.55k | 0% $ 0 | |
| Independent Director | 2.3yrs | no data | no data | |
| Chairman of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | less than a year | US$102.74k | 0% $ 0 | |
| Independent Director | 3.1yrs | no data | no data | |
| Independent Director | less than a year | US$102.74k | 0% $ 0 | |
| Independent Director | 1.1yrs | no data | no data |
2.3yrs
Average Tenure
50yo
Average Age
Experienced Board: BOLD's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.